Eyeground disease therapeutic treatment composition

Details Eyeground disease therapeutic treatment composition Eyeground disease therapeutic treatment composition

A - Human Necessities

61

K

167/147

A61K 31/59 (2006.01)

Patent

CA 2019098

EYEGROUND DISEASE THERAPEUTIC TREATMENT COMPOSITION ABSTRACT OF THE DISCLOSURE An eyeground disease therapeutic treatment composi- tion containing, as an active ingredient, an active vitamin D such as 1.alpha.-hydroxyvitamin D, 1.alpha.,24-dihydroxy- vitamin D, 1.alpha.,25-dihydroxyvitamin D, 24,25-dihydroxy- vitamin D, 1.alpha.,24,25-trihydroxyvitamin D, 24,24-F2- 1.alpha.,25-dihydroxyvitamin D, 26,26,26,27,27,27-F6-1.alpha.,25- dihydroxyvitamin D, 22-oxa-1.alpha.,25-dihydroxyvitamin D, 1.alpha.,24 (R)-dihydroxy-22-dehydrovitamin D-26,27-cyclopropa- ne and 1.alpha.,24(S)-dihydroxy-22-dehydrovitamin D-26,27- cyclopropane.

Affiliated with

Also associated with

Rating

Eyeground disease therapeutic treatment composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Eyeground disease therapeutic treatment composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Eyeground disease therapeutic treatment composition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1466336